Mesenchymal stem cells and their application to rotator cuff pathology: A meta-analysis of pre-clinical studies
Morton-Gonzaba N., Carlisle D., Emukah C., Chorath K., Moreira A.
Meta-analysis with a reported sample of 576 on Rotator Cuff, Chronic Wound, published in Osteoarthr Cartil Open (2020) — summary generated from the PubMed abstract.
Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Meta-analysis
- Journal
- Osteoarthr Cartil Open (2020)
- Reported sample size
- 576
- Source database
- Europe PMC
- PMID
- 36474592
- PMCID
- PMC9718136
- DOI
- 10.1016/j.ocarto.2020.100047
- Citations
- 7
Abstract (original English)
Background Rotator cuff injury (RCI) is a leading cause of morbidity in orthopaedics. Advances in regenerative medicine have led to the novel pleiotropic effects of mesenchymal stromal cells (MSCs) as therapeutic agents for RCI. Objective Conduct a systematic evaluation of available preclinical studies to quantify the effects of MSCs on RCI. Methods A literature search was performed in PubMed, Scopus, Cochrane, CINAHL, and Google Scholar. At least two independent investigators screened animal studies assessing the therapeutic effects of MSCs on: (i) biomechanical testing, imaging, and/or range-of-motion (primary outcome), and (ii) histologic analyses of wound healing, gene/protein expression of regenerative factors, and safety/long-term outcomes (secondary outcome). Meta-analysis data is reported as standardized mean difference (SMD) with 95% confidence interval (CI). Results A total of 858 titles and abstracts were screened; 18 studies (n=576) met inclusion criteria. MSC therapy improved ultimate load failure [SMD -0.43 (95% CI -0.65, -0.22), p Conclusion Administration of MSCs in preclinical models recapitulating RCI improved aspects of shoulder biomechanics, imaging, and collagen formation. Although these findings are promising, future studies should attempt to limit the risk of bias and focus on optimizing MSCs by standardizing methodologies.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Comparing Regenerative Biologics and Standard Pharmacotherapy for Chronic Rotator Cuff Tendinopathy: A Study of PRP, Cell-Based, and Peptide Interventions
Systematic Review on Tendon Injury, Rotator Cuff, Shoulder Pain, Chronic Inflammation, published in J Orthop Sports Med (2026) — summary generated from the PubMed abstract.
- 2026
J Orthop Sports Med - Level AMeta-analysisEurope PMC
Surgical vs. non-surgical therapy for partial tears of the rotator cuff: a systematic review and meta-analysis of pooled studies with indirect comparison
Meta-analysis with a reported sample of 818 on Tendon Injury, Rotator Cuff, Shoulder Pain, published in BMC Musculoskelet Disord (2026) — summary generated from the PubMed abstract.
- 2026
- n = 818
BMC Musculoskelet Disord - Level AMeta-analysisEurope PMC
Comparison of nonsurgical treatment approaches for partial rotator cuff tears: a systematic review and meta-analysis
Meta-analysis with a reported sample of 137 on Rotator Cuff, Shoulder Pain, published in JSES Rev Rep Tech (2026) — summary generated from the PubMed abstract.
- 2026
- n = 137
JSES Rev Rep Tech - Level ASystematic ReviewPubMed
The role of injections of mesenchymal stem cells as an augmentation tool in rotator cuff repair: a systematic review.
Systematic Review with a reported sample of 5 on Tendon Injury, Rotator Cuff, published in JSES Rev Rep Tech (2025) — summary generated from the PubMed abstract.
- 2025
- n = 5
JSES Rev Rep Tech - Level ASystematic ReviewPubMed
Poor consideration of tissue loading in randomised trials of MSC interventions for tendon pathology: A systematic review using the TIDieR framework.
Systematic Review on Tendon Injury, Rotator Cuff, published in J Exp Orthop (2025) — summary generated from the PubMed abstract.
- 2025
J Exp Orthop - Level AMeta-analysisEurope PMC
Combined arthroscopic rotator cuff repair with mesenchymal stem cell augmentation shows similar functional outcomes but a higher structural integrity rate compared with isolated repair: a meta-analysis of comparative stu
Meta-analysis with a reported sample of 415 on Tendon Injury, Rotator Cuff, published in JSES Int (2025) — summary generated from the PubMed abstract.
- 2025
- n = 415
JSES Int